Louisiana State Employees Retirement System Invests $2.34 Million in Teleflex Incorporated $TFX

Louisiana State Employees Retirement System bought a new position in shares of Teleflex Incorporated (NYSE:TFX) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 19,600 shares of the medical technology company’s stock, valued at approximately $2,344,000.

Several other hedge funds have also recently bought and sold shares of the business. Banque Cantonale Vaudoise lifted its position in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares in the last quarter. Hantz Financial Services Inc. increased its position in shares of Teleflex by 40.5% in the fourth quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock worth $48,000 after acquiring an additional 113 shares in the last quarter. UMB Bank n.a. increased its position in shares of Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 113 shares in the last quarter. Maryland State Retirement & Pension System raised its stake in shares of Teleflex by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock valued at $1,056,000 after acquiring an additional 129 shares during the period. Finally, CIBC Asset Management Inc raised its stake in shares of Teleflex by 3.4% in the 4th quarter. CIBC Asset Management Inc now owns 4,380 shares of the medical technology company’s stock valued at $535,000 after acquiring an additional 145 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

TFX opened at $127.84 on Tuesday. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $139.67. The firm has a market cap of $5.66 billion, a price-to-earnings ratio of -5.61, a PEG ratio of 0.97 and a beta of 0.82. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The company has a fifty day simple moving average of $129.99 and a 200 day simple moving average of $119.64.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. During the same quarter in the previous year, the business posted $1.44 EPS. The firm’s revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts expect that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be paid a $0.34 dividend. The ex-dividend date is Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. Teleflex’s payout ratio is -5.96%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on TFX shares. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Raymond James Financial reissued an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Wall Street Zen raised Teleflex from a “sell” rating to a “hold” rating in a research report on Saturday. Wells Fargo & Company increased their target price on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. Finally, Mizuho set a $140.00 target price on Teleflex in a research note on Friday, May 8th. Four investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $146.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.